Montse Loncà

Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine

Daniel Podzamczer, Elena Ferrer, Pochita Sanchez et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2006 · 137 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Body composition changes after switching from protease inhibitors to raltegravir

Adrián Curran, Estebán Martínez, María Saumoy et al. · AIDS · 2011 · 66 citations

Medicine, Pharmacotherapy, Bone Metabolism +16

Incidence and Risk Factors for Mitochondrial Toxicity in Treated HIV/HCV-Coinfected Patients

Montse Laguno, Ana Milinkovic, Elisa de Lazzari et al. · Antiviral Therapy · 2005 · 46 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Inflammatory Markers Related to Microbial Translocation Among HIV-Infected Pregnant Women: A Risk Factor of Preterm Delivery

F. Figueras, Oriol Coll, Anna Goncé et al. · The Journal of Infectious Diseases · 2015 · 44 citations

Life Sciences, Immunology, Obstetrics +17

Metabolic, mitochondrial, renal and hepatic safety of enfuvirtide and raltegravir antiretroviral administration: Randomized crossover clinical trial in healthy volunteers

Sergio Espuelas Barroso, Constanza Morén, Àlex G. Segura et al. · PLoS ONE · 2019 · 23 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17